peripheral arterial disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) patients with in-stent restenosis in superficial femoral artery. 2) peripheral arterial disease (Rutherford 1-5 categories) 3) patients meeting endovascular therapy criteria. 4) patients who can understand this study and provided written informed consent 5) patients aged over 20 years at the time of informed consent
Exclusion criteria
Exclusion criteria: 1)patients with in-stent occlusion in superficial femoral artery. 2)patients with all three occlusion artery below the knee 3)patients with uncontrollable heart failure 4)patients with acute limb ischemia or acute thrombotic occlusion 5)patients can not recieve antiplatelet therapy 6)female patients during pregnancy or breast-feeding 7)patients judged inappropriate for this study by physician
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Restenosis with duplex ultrasonography at 6 months after balloon angioplasty | — |
Secondary
| Measure | Time frame |
|---|---|
| 1)Rutherford category at 12 months after balloon angioplasty 2)Restenosis with duplex ultrasonography at 12 months after balloon angioplasty | — |
Countries
Japan
Contacts
Department of Internal Medicine, Kobe University Graduate School of Medicine Division of Cardiovascular Medicine